Bladder Cancer - Results from #240

Efficacy and Feasibility of Pre-surgical Exercise in Bladder Cancer Patients Scheduled for Open Radical Cystectomy. February 6, 2023

High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial. February 6, 2023

Health-Related Quality of Life after Robotic-Assisted vs Open Radical Cystectomy: Analysis of a Randomized Trial. February 3, 2023

Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancer. February 3, 2023

Impact of Repeat Transurethral Resection of Muscle-Invasive Bladder Cancer - Expert Commentary February 2, 2023

Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not Therapeutic February 2, 2023

New Study Publication Reinforces the Clinical Benefits of Blue Light Cystoscopy in the ASC Setting; Supports Ongoing Initiatives to Further Improve Reimbursement February 2, 2023

News in the classification of WHO 2022 bladder tumors. February 2, 2023

Preoperative Systemic Inflammatory Markers as a Significant Prognostic Factor After TURBT in Patients with Non-Muscle-Invasive Bladder Cancer. February 2, 2023

Robotic radical cystectomy - more precision needed? February 1, 2023

En-bloc resection of non-muscle invasive bladder cancer: does it really make a difference? February 1, 2023

A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study. February 1, 2023

A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer. January 31, 2023

Association Between Antibiotic Prophylaxis Before Cystectomy or Stent Removal and Infection Complications: A Systematic Review. January 31, 2023

Altered Urinary Microbiome in Patients with Bladder Cancer - Expert Commentary January 30, 2023

Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1. January 30, 2023

Gene Screening for Prognosis of Non-Muscle-Invasive Bladder Carcinoma under Competing Risks Endpoints. January 30, 2023

Bladder cancer is associated with decreased urinary microbiota diversity and alterations in microbial community composition. January 30, 2023

Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer. January 27, 2023

Risk Factors Involved in the High Incidence of Bladder Cancer in an Industrialized Area in North-Eastern Spain: A Case-Control Study. January 27, 2023

Page 13 of 466